DEVELOPMENT AND REGISTRATION. 3.1 As of the Effective Date and subject always to MSD's retained rights to the Patents, the Licensee shall have full control, responsibility (financial and otherwise) and authority over development, registration, importation, manufacture, and commercialisation of the Products to be sold or supplied by the Licensee in the Territory under this Agreement.
DEVELOPMENT AND REGISTRATION. 3.1 As of the Effective Date and subject always to AbbVie’s retained rights to AbbVie Patents, the Licensee shall have full control, responsibility (financial and otherwise) and authority over development, registration, importation, manufacture and commercialisation of the Licensed Products to be sold or supplied by the Licensee in the Territory under this Agreement.
DEVELOPMENT AND REGISTRATION. 4.1 As of the Sublicence Effective Date and subject always to Novartis’s retained rights to the Manufacturing Patent and the Patents (and those of its licensees), the Licensee shall have full control, responsibility (financial and otherwise) and authority over development, registration, importation, manufacture and commercialisation of the Products to be sold orsupplied by the Licensee in the Field in the Territory under this Agreement.
DEVELOPMENT AND REGISTRATION. 4.1. The Sublicensee agrees that it will manufacture the Product in a manner consistent with (i) WHO pre-qualification standards; or (ii) the standards of any Stringent Regulatory Authority, defined as a regulatory authority which was a member or observer of the International Council on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (“ICH”), or associated with an ICH member through a legally-binding, mutual recognition agreement, in each case as before 23 October 2015. Where such standards are not yet available, the Sublicensee will obtain temporary approval through a WHO Expert Review Panel, as appropriate and if applicable.
DEVELOPMENT AND REGISTRATION. 4.1 As of the Effective Date and subject always to ViiV’s retained rights to the Patents and Non-Territory Patents (and that of its licensees), the Licensee shall have full control, responsibility (financial and otherwise) and authority over development, registration, importation, manufacture and commercialisation of the Products to be sold or supplied by the Licensee in the Territory under this Agreement.
DEVELOPMENT AND REGISTRATION. Roche and Agouron acknowledge their mutual intention generally to take a collaborative, commercially reasonable approach to the timely development of the Compound and Products arising out of the Development Program for cancer indications. The parties further acknowledge their mutual willingness to discuss ad hoc agreements to establish appropriate mechanisms for such collaborative development. Recognizing the importance of timely initiation of development activities, however, Roche and Agouron agree to the following basic approach to development of Products for cancer indications and to the conduct of the Global Joint Development Committee activities.
DEVELOPMENT AND REGISTRATION. 17 Section 4.03 Marketing...............................................................................21 Section 4.04 Supply of Compound and Product..........................................................26
DEVELOPMENT AND REGISTRATION. 11.1 [Text has been redacted] [Text has been redacted]
DEVELOPMENT AND REGISTRATION. 3.1 As of the Effective Date and subject always to Merck's retained rights to the Licensed Patent Rights, the Licensee shall have full control, responsibility (financial and otherwise) and authority over development, registration, importation, manufacture and commercialisation of the Products to be sold or supplied by the Licensee in the Territory under this Agreement.
DEVELOPMENT AND REGISTRATION. 4.01 As of the EFFECTIVE DATE, LICENSEE shall have full control and authority over, and shall be solely responsible for PRODUCTS, including but not limited to the development, registration, manufacture and commercialization of PRODUCTS in the TERRITORY. LICENSEE will exercise its reasonable efforts and diligence in developing and commercializing a PRODUCT in accordance with its business, legal, medical and scientific judgment, and in undertaking investigations and actions required to obtain appropriate governmental approvals to market a PRODUCT in the TERRITORY. All such activity shall be undertaken at LICENSEE's expense.
